Tag: Cancer

  • Nation & World

    Coffee tied to lower prostate cancer risk

    Men who regularly drink coffee appear to have a lower risk of developing a lethal form of prostate cancer, according to a new study led by Harvard School of Public Health researchers.

    4 minutes
  • Nation & World

    Cancer cells’ survival kit

    Harvard-affiliated scientists at Dana-Farber Cancer Institute have discovered new details of how cancer cells escape from tumor suppression mechanisms that normally prevent these damaged cells from multiplying.

    5 minutes
  • Nation & World

    Harvard rallies against cancer

    Now through April 8, team up with other Harvard faculty and staff members to shut out cancer through Harvard Community Gifts.

    1 minute
  • Nation & World

    Multiple myeloma genome unveiled

    Harvard scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer.

    6 minutes
  • Nation & World

    Dilemmas of destiny

    As genetic testing and its offspring — personalized medicine — have matured, patients and doctors have become entangled in such issues as how to best share at-risk information, access treatment options, and weigh decisions about threats to the young and unborn. And sometimes these issues mushroom, becoming quandaries for society as a whole.

    9 minutes
  • Nation & World

    Beyond DNA

    On a day when Harvard celebrated the accomplishments of the Human Genome Project, the Radcliffe Institute hosted a scientist whose work focuses not just on DNA, but on the mechanisms that control its expression.

    2 minutes
  • Nation & World

    Daffodil Days are here again

    Members of the Harvard community are invited to purchase fresh bouquets of daffodils for $10 to support the research and programs of the American Cancer Society. The deadline to order is March 1.

    1 minute
  • Nation & World

    BIDMC’s Pandolfi to receive cancer research award

    Cancer geneticist Pier Paolo Pandolfi at Harvard-affiliated Beth Israel Deaconess Medical Center is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research.

    1 minute
  • Nation & World

    Deadline looms for two HMS fellowships

    Two fellowships in Harvard Medical School’s media fellowship program are open for applications from reporters.

    1 minute
  • Nation & World

    Gregory Verdine wins prize for cancer research

    Gregory Verdine has won the 2011 American Association for Cancer Research Award for Outstanding Achievement in Chemistry in Cancer Research.

    1 minute
  • Nation & World

    Sick to death

    Harvard School of Public Health researchers are mounting a major study of chronic disease in four African nations, which organizers hope will provide a foundation for understanding and treating chronic ailments like heart disease, diabetes, and cancer.

    4 minutes
  • Nation & World

    The rise of chronic disease

    Heart disease, diabetes, and other chronic diseases are becoming enormous problems in the developing world and need more attention even as the challenge of fighting infectious diseases like AIDS shows no sign of abating, according to Institute of Medicine President Harvey Fineberg.

    3 minutes
  • Nation & World

    Targeting lung cancer

    An initial study of a new treatment for a form of lung cancer seems so promising it has been jumped from Phase 1 to Phase 3 clinical trials.

    4 minutes
  • Nation & World

    When ‘watch and wait’ works best

    Harvard researchers have found that as many as 50 percent of young girls treated for germ cell ovarian tumors might be spared chemotherapy using a “watch and wait” strategy to determine if the follow-up treatment is needed.

    3 minutes
  • Nation & World

    It all adds up

    New mathematical modeling by scientists from Harvard and other institutions reinforces the view of cancer as a complex culmination of many mutations.

    4 minutes
  • Nation & World

    Poised for progress

    A discovery by scientists at Harvard-affiliated Dana-Farber Cancer Institute may lead to an effective way of operating the immune system’s internal “control panel,” improving therapies for a variety of diseases.

    4 minutes
  • Nation & World

    Health leaders push for better cancer care in developing countries

    Once thought to be a problem primarily in the developed world, cancer is now a leading cause of death and disability in poorer countries. Almost two-thirds of the 7.6 million cancer deaths in the world occur in low- and middle-income countries.

    4 minutes
  • Nation & World

    Urgent matters

    According to a paper to be published online in the Lancet on Aug. 16, the international community must discard the notion that cancer is a “disease of the rich” and approach it as a global priority.

    4 minutes
  • Nation & World

    Six Harvard affiliates receive Damon Runyon fellowships

    Six Harvard affiliates have been named recipients of fellowships by the Damon Runyon Cancer Research Foundation, a nonprofit organization focused on supporting exceptional early-career researchers and innovative cancer research.

    3 minutes
  • Nation & World

    Using nanotechnology to improve a cancer treatment

    Harvard and Brigham and Women’s Hospital researchers have devised a method that may allow clinicians to use higher doses of a powerful chemotherapy drug that has been limited because it is toxic not only to tumors but to patients’ kidneys.

    3 minutes
  • Nation & World

    Improving a cancer drug

    Researchers, led by Harvard Medical School Assistant Professor Shiladitya Sengupta, have devised a way to improve a low-cost, effective cancer drug, cisplatin, whose use has been limited by its toxicity.

    3 minutes
  • Nation & World

    New drug extends life of melanoma patients

    A therapy that multiplies the effect of a natural disease-fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial.

    4 minutes
  • Nation & World

    Bench pressing for a cure

    On May 3, more than 250 Harvard athletes from 18 varsity teams took the Palmer-Dixon Gymnasium by storm for the second annual Bench Press for Breast Cancer Challenge, pumping iron and raising greenbacks for the Susan G. Komen for the Cure.

    4 minutes
  • Nation & World

    Evening with Champions

    With her spotlight purring like an old projector, Linda Yao ’10 used a steady hand to follow the cast of famed figure skaters as they shaved graceful ribbons into the ice during “An Evening with Champions.”

    2 minutes
  • Nation & World

    Peering into gearworks of FDA

    Daniel Carpenter’s new book, “Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA,” probes the workings of a crucial federal safety agency that often is either lionized or demonized.

    3 minutes
  • Nation & World

    Sumner M. Redstone donates $1M

    Harvard University today (April 23) announced that Sumner M. Redstone has contributed $1 million to be used by Harvard College and Harvard Law School. This contribution by Redstone, a graduate of both Schools, will establish scholarships for 20 Redstone Scholars to attend Harvard College for the 2010–11 academic year.

    5 minutes
  • Nation & World

    Diabetes drug tied to reduced breast cancer risk

    Women who have used the diabetes drug metformin for more than five years may have a lower risk of breast cancer than diabetic women on other treatments, a new study finds…

    1 minute
  • Nation & World

    Radiation use may raise adult cancer risk

    NEW YORK — Women’s risk of developing breast cancer may increase as much as 20-fold if they were treated with chest radiation for malignancies as children or young adults, according…

    1 minute
  • Nation & World

    Childhood cancer survivors may face shortened lifespan, study reveals

    Although more children today are surviving cancer than ever before, young patients successfully treated in the 1970s and 80s may live a decade less, on average, than the general population,…

    5 minutes
  • Nation & World

    Treatment resistance in some cancer cells may be reversible

    The ability of cancer cells to resist treatment with either targeted drug therapies or traditional chemotherapy may, in some cases, result from a transient state of reversible drug “tolerance.”  In…

    3 minutes